Phase Holographic Imaging PHI AB (FRA:L5W) Total Liabilities: €0.38 Mil (As of Oct. 2025)


What is Phase Holographic Imaging PHI AB Total Liabilities?

Phase Holographic Imaging PHI AB FRA:L5W Total Liabilities is €0.38 Mil as of Oct. 2025. The stock has 5 warning signs investors should review.

Phase Holographic Imaging PHI AB's Total Liabilities for the quarter that ended in Oct. 2025 was €0.38 Mil.

Phase Holographic Imaging PHI AB's quarterly Total Liabilities declined from Apr. 2025 (€0.65 Mil) to Jul. 2025 (€0.43 Mil) and declined from Jul. 2025 (€0.43 Mil) to Oct. 2025 (€0.38 Mil).

Phase Holographic Imaging PHI AB's annual Total Liabilities declined from Apr. 2023 (€2.73 Mil) to Apr. 2024 (€2.41 Mil) and declined from Apr. 2024 (€2.41 Mil) to Apr. 2025 (€0.65 Mil).


Phase Holographic Imaging PHI AB Total Liabilities Historical Data

* Premium members only.

The historical data trend for Phase Holographic Imaging PHI AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phase Holographic Imaging PHI AB Total Liabilities Chart

Phase Holographic Imaging PHI AB Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.61 2.97 2.73 2.41 0.65

Phase Holographic Imaging PHI AB Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.69 0.83 0.65 0.43 0.38

Phase Holographic Imaging PHI AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Phase Holographic Imaging PHI AB's Total Liabilities for the fiscal year that ended in Apr. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.472+(0.176+5.5511151231258E-17
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.65

Total Liabilities=Total Assets (A: Apr. 2025 )-Total Equity (A: Apr. 2025 )
=5.089-4.44
=0.65

Phase Holographic Imaging PHI AB's Total Liabilities for the quarter that ended in Oct. 2025 is calculated as

Total Liabilities=Total Assets (Q: Oct. 2025 )-Total Equity (Q: Oct. 2025 )
=3.364-2.982
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €0.38 Mil mean?
Phase Holographic Imaging PHI AB (FRA:L5W) has a Total Liabilities of €0.38 Mil as of Oct. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Phase Holographic Imaging PHI AB and its competitors.
Is Phase Holographic Imaging PHI AB's Total Liabilities too high?
Phase Holographic Imaging PHI AB's current Total Liabilities is €0.38 Mil.
How does Phase Holographic Imaging PHI AB's Total Liabilities compare to ABT and BSX?
Phase Holographic Imaging PHI AB's Total Liabilities of €0.38 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Phase Holographic Imaging PHI AB and its competitors. Phase Holographic Imaging PHI AB's current Total Liabilities is €0.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phase Holographic Imaging PHI AB stock overvalued right now?
Phase Holographic Imaging PHI AB (FRA:L5W) has a current Total Liabilities of €0.38 Mil. The stock's GF Value™ is €0.23, compared to a current price of €0.04 — trading 81% below its estimated fair value. The current Total Liabilities is €0.38 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Phase Holographic Imaging PHI AB (FRA:L5W), the current Total Liabilities is €0.38 Mil as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Phase Holographic Imaging PHI AB Business Description

Address Skiffervagen 48, Lund, SWE, 224 78
Phase Holographic Imaging PHI AB is a medical device company that develops and markets non-invasive time-lapse imaging instruments used for the quantitative long-term analysis of living cell cultures. The company's commercial HoloMonitor products are based on Quantitative Phase Imaging (QPI) technology, which is used for real-time cell quality evaluation. Geographically, it has presence in Lund, Sweden, with offices in Boston, MA and Winston-Salem, NC.